Potential Impact of Treatment with Inotuzumab Ozogamicin on Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
暂无分享,去创建一个
C. Zwaan | F. Locatelli | P. Bader | B. De Moerloose | P. Hoogerbrugge | S. Rheingold | E. Jacoby | B. Vormoor | E. Brivio | J. Fuster | Jeremy D. Rubinstein | K. Kałwak | F. Calkoen | A. Leahy | M. O’Brien | V. Ceolin